IGHE and asthma: The data shown, therefore, urge patients with an allergic type of asthma to consider the best possible therapeutic approach, both in patients already treated with anti-IgE and in biological-naïve patients, in order to consider switching or even using dupilumab as a biological therapy, at the first instance.